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Abstract 1 
In this study, the bioaccessibility of phenolic compounds after in vitro gastro-intestinal digestion of 2 
two cherry cultivars was assessed. The phenolic profile was modified during in vitro digestion, with 3 
a considerable decrease of total and individual phenolic compounds. Hydroxycinnamic acids and 4 
especially coumaroylquinic acids showed the highest bioaccessibility. Isomerisation of 5 
caffeoylquinic and coumaroylquinic acids was observed after in vitro digestion. Modification of the 6 
phenolic profile after digestion resulted in an increased or decreased scavenging activity depending 7 
on the assay. In vitro digested phenolic-rich fractions also showed anti-proliferative activity against 8 
SW480 but no effect against Caco-2 cell lines. Both Caco-2 and SW480 cell lines were able to 9 
metabolize cherry phenolic compounds with remarkable differences. An accumulation of 10 
glycosylated flavonols was observed in SW480 medium. In conclusion, phenolic compounds from 11 
cherries and especially hydroxycinnamic acids were efficiently released and remained bioaccessible 12 
after in vitro digestion, resulting in antioxidant and anti-proliferative activities. 13 
 14 
Keywords: mass spectrometry, bioaccessibility, anti-proliferative activity, hydroxycinnamic acids, 15 
Caco-2, SW48016 
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1. Introduction 17 
Sweet cherry (Prunus avium L., Rosacea) is a commercially important table fruit highly appreciated 18 
by consumers due to its taste, colour and sweetness, but also for its nutritional properties and 19 
beneficial effects (Kelley et al. 2018). Sweet cherry fruits contain different phenolic compounds, 20 
including anthocyanins, flavan-3-ols and hydroxycinnamic acids that have been related to the 21 
healthy properties of these fruits (Ferretti et al. 2010). Indeed, cherries were considered as the main 22 
dietary source of anthocyanins within the context of the Mediterranean Diet (Godos et al. 2017).  23 
Recently, our research group thoroughly investigated the phenolic profile of different sweet cherry 24 
varieties, from pale yellow flesh and slightly reddish skin to dark red cultivars, using mass 25 
spectrometry (Martini et al. 2017). Among the 86 identified compounds, 3-coumaroylquinic acid, 26 
epicatechin and cyanidin-3-rutinoside were present at the highest concentrations (Martini et al. 27 
2017). The amount of individual phenolic compounds in sweet cherries is variable and strongly 28 
dependent on the cultivars (Martini et al. 2017; Picariello et al. 2016). The dark red cultivars are 29 
rich in anthocyanins, whereas the slightly reddish cultivars are rich in hydroxycinnamic acids and/or 30 
flavan-3-ols (Martini et al. 2017; Picariello et al. 2016). 31 
There are several human intervention studies suggesting that cherry consumption may have 32 
beneficial effects on markers of cardiovascular disease risk (Kelley et al. 2018). Short-term 33 
supplementation of cherries reduced both systolic and diastolic blood pressure in diabetic women or 34 
hypertensive subjects (Keane et al. 2016; Kent et al. 2016). The effect on blood pressure correlated 35 
in time with changes in plasma cyanidin-3-glucoside metabolites such as vanillic and 36 
protocatechuic acids (Keane et al. 2016). Furthermore, cherry intake ameliorated the lipid profile of 37 
overweight and obese subjects by reducing the level of very-low density lipoproteins and increasing 38 
the amount of high-density lipoproteins (Martin et al., 2011). Some mechanisms have been 39 
proposed to explain the protective effect of cherries such as antioxidant activity, increased 40 
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expression of nitric oxide synthase and decreased expression of endothelin-1 (Kelley et al. 2013; 41 
Edwards et al. 2015).  42 
Cherry intake also resulted in an anti-cancer activity at gastro-intestinal tract level (Ferretti et al. 43 
2010). ApcMin mice consuming cherries, anthocyanins or cyanidin had significantly fewer and 44 
smaller intestinal adenomas than ApcMin mice consuming the control diet (Kang et al. 2003). The 45 
protective effect of cherries against intestinal cancer has been attributed to the biological activities 46 
of anthocyanins. Extracts of sweet cherries as well as anthocyanins and cyanidin aglycone showed 47 
in vitro anti-proliferative activity against human cancer cells from the colon (HT-29 and HCT-15) 48 
and stomach (MKN45) (Bastos et al. 2015; Serra et al. 2011; Kang et al. 2003). These in vitro 49 
studies with cell culture models, carried out with pure phenolic compounds or cherry extracts, did 50 
not take into account the bioaccessibility and gastro-intestinal tract stability of the phenolic 51 
compounds. Some phenolic compounds, and especially anthocyanins, are unstable under the gastro-52 
intestinal tract conditions (Yang et al. 2018; Bouayed et al. 2012; Juániz et al. 2017). Indeed, cherry 53 
phenolic compounds are entrapped in a solid food matrix and only the compounds released from the 54 
food matrix may exert their beneficial effects in the gastro-intestinal tract or at systemic level 55 
(Tagliazucchi et al. 2010). Furthermore, only few recent in vitro studies investigated the metabolism 56 
and/or the stability of phenolic compounds in cell cultures (Aragonès et al. 2017; Mele et al., 2016; 57 
Sala et al., 2015). 58 
Therefore, this work aimed to investigate the effect of in vitro gastro-intestinal digestion on the 59 
bioaccessibility and antioxidant properties of cherry phenolic compounds from two different 60 
cultivars (Celeste and Durone Nero I). In addition, the anti-proliferative activity and the cell 61 
metabolism of in vitro digested cherry phenolic compounds against two models of human colon 62 
adenocarcinoma cell lines were assessed.  63 
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2. Materials and methods 64 
2.1. Materials  65 
Phenolic compound standards, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox), 66 
2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,4,6-tri(2-pyridyl)-S-triazine 67 
(TPTZ), Folin-Ciocalteau phenol reagent were purchased from Sigma (Milan, Italy). Methanol and 68 
formic acid were obtained from Carlo Erba (Milan, Italy). All MS/MS reagents were from Bio-Rad 69 
(Hercules, CA, U.S.A.). Chemicals and enzymes for the digestion procedure were purchased from 70 
Sigma-Aldrich (Milan, Italy). All the materials and chemicals for cell culture were from Euroclone 71 
(Milan, Italy). MTS cell proliferation assay kit was purchased from Promega (Milan, Italy). Solid 72 
phase extraction (SPE) column (C18, 50 μm, 60 Å, 500 mg) were supplied by Waters (Milan, Italy). 73 
The absorbance was read using a Jasco V-550 UV/Vis spectrophotometer.  74 
 75 
2.2. Cherry cultivars 76 
Two sweet cherry (Prunus avium) cultivars (Celeste and Durone Nero I) were harvested at full 77 
maturity in Vignola (Modena province, Italy). For each variety, about 2 kg of cherries were 78 
randomly sampled from several trees and processed immediately or frozen within 1 h after 79 
harvesting and stored at -80°C until used. The two cherry cultivars were selected according to the 80 
different skin and flesh colours and phenolic composition (Martini et al. 2017). Celeste cultivar 81 
presented a pale red flesh and a bright red skin and predominantly contained hydroxycinnamic acids 82 
and flavan-3-ols. Durone Nero I instead was a dark red cultivar rich in anthocyanins. 83 
 84 
2.3. In vitro gastro-intestinal digestion of cherry cultivars and preparation of the chemical 85 
extracts 86 
For the in vitro digestion, the protocol previously developed within the COST Action INFOGEST 87 
was followed (Minekus et al. 2014). The fluids (simulated salivary, gastric and intestinal fluids) 88 
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were prepared according to Minekus et al. (2014). Salivary phase was simulated by homogenizing 89 
with a laboratory blender five grams of each cherry cultivar in presence of 5 mL of the stock 90 
simulated salivary fluid solution. After homogenization, 150 U/mL of porcine α-amylase were 91 
added and the samples were incubated for 5 min at 37°C in a rotating wheel. The gastric phase of 92 
the digestion was carried out by adding to the bolus 10 mL of simulated gastric fluid. After pH 93 
adjustment to 2.0 with 6 mol/L HCl, 2000 U/mL of pepsin were added. After 2 h of incubation at 94 
37°C, the final intestinal step was carried out by adding 15 mL of simulated intestinal fluid. Then, 95 
the pH was adjusted to 7.0, supplemented with pancreatin and the samples were incubated at 37°C 96 
for 2 h. All samples were immediately cooled on ice and frozen at –80°C for further analysis. The 97 
digestions were performed in triplicate.  98 
In addition, phenolic compounds were extracted from each cherry cultivar (chemical extract) as 99 
reported in Martini et al. (2017). The extractions were performed in triplicate.  100 
 101 
2.4. Preparation of the phenolic-rich fractions 102 
Chemical extracts and samples collected at the end of the in vitro digestion were then passed 103 
through a SPE column preconditioned with 4 mL of acidified methanol (containing 0.1% of formic 104 
acid), followed by 5 mL of acidified water (containing 0.1% of formic acid). Elution was carried 105 
out with acidified water (6 mL) to eliminate the unbound material and phenolic compounds were 106 
then desorbed with 3 mL of acidified methanol. The obtained phenolic-rich extracts were then used 107 
for the subsequent analysis. Each sample was extracted in triplicate. 108 
 109 
2.5. Identification and quantification of phenolic compounds by liquid chromatography 110 
electrospray ionization ion trap mass spectrometry (LC-ESI-IT-MS) 111 
Phenolic-rich fractions from chemical extracts and in vitro digested samples were analysed on 112 
HPLC Agilent 1200 Series system equipped with a C18 column (HxSil C18 Reversed phase, 113 
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250×4.6 mm, 5 μm particle size, Hamilton Company, Reno, Nevada, USA) as reported in Martini et 114 
al. (2017). The mobile phase composition was (A) H2O/formic acid (99:1, v/v) and (B) 115 
acetonitrile/formic acid (99:1, v/v). After 0.5 min at 4% B, the gradient linearly ramped up to 30% 116 
B in 60 min. The mobile phase composition was raised up to 100% B in 1 min and maintained for 5 117 
min in order to wash the column before returning to the initial condition. The flow rate was set at 1 118 
mL/min. The samples were injected in the amount of 20 µL. After passing through the column, the 119 
eluate was split and 0.3 mL/min were directed to an Agilent 6300 ion trap mass spectrometer. Two 120 
MS experiments were performed, one in negative ion mode and one using positive ionization (for 121 
anthocyanins), under the same chromatographic conditions. Identification of phenolic compounds in 122 
all samples was carried out using full scan, data-dependent MS2 scanning from m/z 100 to 800 and 123 
selected reaction monitoring. MS operating conditions, limits of detection (LOD) and limits of 124 
quantification (LOQ) for the different standards are reported in Martini et al. (2017). 125 
Quantitative results were expressed as μmol of compounds per 100 g of cherry.  126 
 127 
2.6. Bioaccessibility calculation 128 
The percentage bioaccessibility of phenolic compounds after in vitro gastro-intestinal digestion was 129 
calculated as follow: 130 
	
 =
CC
CC ∗ 100 131 
Where CCd is the concentration of total or individual phenolic compounds in the phenolic-rich 132 
fraction from in vitro digested sample and CCe is the concentration in the phenolic-rich fraction 133 
from the chemical extract. 134 
 135 
2.7. Antioxidant activity assays 136 
The antioxidant properties of the phenolic-rich fractions obtained from chemical extracts and in 137 
vitro digested samples were detailed by using four different assays.  138 
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The ABTS (2,2’-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) and ferric reducing power 139 
(FRAP) assays were performed according to the protocols described by Re et al. (1999) and Benzie 140 
and Strain (1996), respectively. The capacity to scavenge hydroxyl and superoxide anion radicals 141 
were evaluated according to the methods reported by Martini et al. (2017). 142 
The results were expressed as μmol of trolox equivalent per mmol of total phenolic compounds.  143 
 144 
2.8. Cell cultures and anti-proliferative activity of cherry phenolic-rich fractions 145 
Human adenocarcinoma Caco-2 cells were cultured in Dulbecco’s Modified Eagle’s Medium 146 
(DMEM) supplemented with 10% foetal bovine serum (FBS), 1% antibiotic mix (streptomycin and 147 
penicillin) and 2 mmol/L L-glutamine. Human adenocarcinoma SW480 cells were cultured in 148 
Leibowitz medium supplemented with 10% FBS, 1% antibiotic mix (streptomycin and penicillin) 149 
and 2 mmol/L L-glutamine. Cells were maintained at 37°C in a humidified atmosphere of 5% CO2.  150 
Cells were seeded at 5x103/100 μL and 10x103/100 μL for Caco-2 and SW480, respectively, in 96-151 
well plates for 24 h to allow cell adhesion to the bottom of the wells. 152 
For the anti-proliferative assays, a colorimetric method for the sensitive quantification of viable 153 
cells was performed, using MTS assay kit. 100 μL of digested and un-digested cherry phenolic-rich 154 
fractions diluted in cell culture media at different concentrations were added to the cell plates and 155 
incubated for 24 h. At the end of the treatments, media were refreshed with 180 μL of culture media 156 
and 20 μL of MTS reagent were added to each well. After 4 h of incubation at 37°C, the absorbance 157 
was measured at the wavelength of 490 nm using a microplate reader and results were expressed as 158 
IC50. IC50 was defined as the concentration of phenolic compounds required to inhibit 50% cell 159 
proliferation and expressed as μmol of total phenolic compounds/L. The IC50 values were 160 
determined using nonlinear regression analysis and fitting the data with the log (inhibitor) vs. 161 
response model generated by GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). 162 
 163 
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2.9. Liquid chromatography coupled to mass spectrometry (LC-MS/MS) analysis of cell media 164 
Cell culture supernatants were collected at the end of the experiments and analysed by LC-MS/MS 165 
to determine the cell metabolism of the cherry phenolic compounds. Cell media were extracted 166 
according to Sala et al. (2015) and analysed using a HPLC Agilent 1200 Series system equipped 167 
with an Agilent 6300 ion trap mass spectrometer as reported above. Separations were performed 168 
using a C18 column (HxSil C18 Reversed phase, 250×4.6 mm, 5 μm particle size, Hamilton 169 
Company, Reno, Nevada, USA), with an injection volume of 40 μL and elution flow rate of 1 170 
mL/min. The mobile phase composition, the gradient and MS operating conditions are the same as 171 
reported above. 172 
 173 
2.10. Statistic 174 
All data are presented as mean ± SD for three replicates for each prepared sample. One-way 175 
analysis of variance (one-way ANOVA) with Tukey’s post-hoc test was applied using Graph Pad 176 
prism 6.0 (GraphPad software, San Diego, CA, U.S.A.). The differences were considered 177 
significant with P<0.05.178 
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3. Results and discussion 179 
3.1. In vitro bioaccessibility of phenolic compounds in cherry cultivars  180 
Table 1 shows data about the bioaccessibility of individual phenolic compounds in the two analysed 181 
cherry cultivars. The MS data of the individual phenolic compounds are reported in Martini et al. 182 
(2017). 183 
A total of 57 and 56 phenolic compounds were identified and quantified in the chemical extracts of 184 
cherry cultivars Celeste and Durone Nero I, respectively (Table 1). In both the cultivars, 3-185 
coumaroylquinic acid (found as cis and trans isomers) was the main phenolic compound accounting 186 
for 40.6% and 31.3% of the total compounds in Celeste and Durone Nero I, respectively. In general, 187 
hydroxycinnamic acids were the most representative class of phenolic compounds in both the 188 
cultivars (54.2% and 42.2% of the total phenolic compounds in Celeste and Durone Nero I, 189 
respectively). From a quantitative point of view, flavan-3-ols were the second class of phenolic 190 
compounds in both the cultivars (40.7% and 33.4% of the total phenolic compounds in Celeste and 191 
Durone Nero I, respectively). Anthocyanins accounted for the 15.4% of total compounds in the 192 
cultivar Durone Nero I whereas their incidence was about 3% in the cultivar Celeste. Finally, small 193 
amounts of others flavonoids were also detected in both the cultivars. 194 
The phenolic compounds profile was significantly modified from a qualitative and quantitative 195 
point of view after in vitro gastro-intestinal digestion (Figure 1 and Table 1). Only 25 and 39 of the 196 
original phenolic compounds were identified after simulated digestion of the cultivars Celeste and 197 
Durone Nero I, respectively. This meant that 56% and 30% of individual phenolic compounds were 198 
not bioaccessible. 199 
Total phenolic compounds determined by LC-ESI-IT-MS/MS in the cherry cultivars chemical 200 
extracts were significantly higher (P<0.05) than those found after in vitro gastro-intestinal digestion 201 
(Figure 1A and Table 1). The bioaccessibility of total phenolic compounds was 39.7% and 29.9% 202 
in the cultivars Celeste and Durone Nero I, respectively. Hydroxycinnamic acids were the most 203 
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abundant phenolic compounds released from cherry matrices with a bioaccessibility of 71.7% and 204 
46.5% in the cultivars Celeste and Durone Nero I, respectively (Figure 1B and Table 1). At the end 205 
of the digestion, hydroxycinnamic acids represented the 98.0% and 65.5% of total phenolic 206 
compounds in the cultivars Celeste and Durone Nero I, respectively (Figure 1H). These compounds 207 
were particularly stable under gastro-intestinal conditions and easily released from the cherry 208 
matrices. The stability of hydroxycinnamic acids under gastro-intestinal conditions has been already 209 
reported. For example, Tagliazucchi et al. (2012) found that only the 30% of hydroxycinnamic 210 
acids were degraded during in vitro digestion of a coffee beverage whereas Monente et al. (2015) 211 
assessed a 14% decrease during in vitro digestion of a spent coffee water extract. Previous studies 212 
with solid food matrices confirmed the easy release of hydroxycinnamic acids during in vitro 213 
digestion. The bioaccessibility of hydroxycinnamic acids was 60-67% in cooked cardoon, 32-57% 214 
in apple and about 77% in frozen sweet cherries subjected to gastro-intestinal digestion (Juániz et 215 
al. 2017; Fazzari et al. 2008; Bouayed et al. 2012). This is also in accordance with the recorded 216 
recovery of caffeoylquinic acids (59-77%) in ileal fluid after coffee or apple ingestion by 217 
ileostomists (Erk et al. 2014; Stalmach et al. 2010). The highest release after incubation with 218 
digestive fluids was found for coumaroylquinic acids, followed by feruloylquinic and 219 
caffeoylquinic acids (Table 1 and Figure 2). These results are in accordance with Monente et al. 220 
(2015) and Tagliazucchi et al. (2012) who found that feruloylquinic and caffeoylquinic acids were 221 
quite stable under gastro-intestinal conditions. No data about the stability or bioaccessibility of 222 
coumaroylquinic acids have been published until now. Otherwise, the minor hydroxycinnamic acids 223 
identified in cherries (such as di-hydroxycinnamic acids and lactone derivatives) were not 224 
bioaccessible probably because of their instability in the gastro-intestinal environment (Monente et 225 
al. 2015; Tagliazucchi et al. 2012). The differences between the recoveries of hydroxycinnamic 226 
acids in the two different cherry cultivars could be indicative of a food matrix impact (Figure 2 and 227 
Table 1).  228 
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As reported above, overall coumaroylquinic, caffeoylquinic and feruloylquinic acids were easily 229 
released from food matrices, although changes mainly due to variations in isomers level were 230 
recorded after in vitro digestion. While the 5- and 3-caffeoylquinic acid isomers were found at 231 
lower concentrations after in vitro digestion compared to the chemical extracts, the 4-caffeoylquinic 232 
acid isomers concentration increased significantly (Figure 2A and 2B and Table 1). Acyl migration 233 
of caffeoylquinic acids has been already demonstrated both in vitro with pure standard compounds 234 
or after digestion of coffee and in vivo in ileostomy volunteers (Erk et al. 2014; Monente et al. 235 
2015; Tagliazucchi et al. 2012). Similar results were observed for feruloylquinic acids (Figure 2C 236 
and 2D and Table 1). Otherwise, a different behaviour was observed for coumaroylquinic acids. In 237 
this case, we found remarkable higher concentrations of  4- and 5-coumaroylquinic acid isomers 238 
after simulated digestion (Figure 2E and 2F and Table 1). On the contrary, the concentration of 3-239 
coumaroylquinic acid isomers was lower after digestion than that recorded after chemical 240 
extraction. Previously, Kahle et al. (2011) reported isomerization of 4-coumaroylquinic acid to 3- 241 
and 5-coumaroylquinic acids after incubation of standard compounds with intestinal fluids. These 242 
results, instead, suggested that coumaroylquinic acids were subjected to isomerization from the 3-243 
acyl to 4- and 5-acyl structures.  244 
Simple hydroxycinnamic acids (coumaric, caffeic and ferulic acids) were not found after intestinal 245 
digestion, suggesting that relevant hydrolysis of ester bond did not occur during in vitro digestion. 246 
On the other hand, incubation of caffeoylquinic and coumaroylquinic acids standards resulted in the 247 
appearance of simple acids after 6 h of incubation in intestinal fluids (Kahle et al. 2011). 248 
Flavan-3-ols, which were the second most abundant class of phenolic compounds in cherry 249 
chemical extracts, were characterized by a very low bioaccessibility (Figure 1C and Table 1). In 250 
the cultivar Celeste, only (epi)catechin-3-gallate was detected after gastro-intestinal digestion. In 251 
the cultivar Durone Nero I we also found monomeric and dimeric (epi)catechins, although 252 
(epi)catechin-3-gallate was still the flavan-3-ol with the highest bioaccessibility. The 253 
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bioaccessibility of monomeric catechins seems to be highly dependent on the food matrix. During 254 
in vitro digestion of green tea, Green et al. (2007) found that only the 32% of epicatechin was 255 
degraded. High stability of monomeric catechins was also described when the standard compounds 256 
were incubated with gastro-intestinal fluids (Tagliazucchi et al. 2010). However, in vitro digestion 257 
of apple varieties, grape or wine resulted in an important degradation of monomeric catechins 258 
(Bouayed et al. 2012; Lingua et al. 2018). Whether catechin and epicatechin were degraded or not 259 
released from cherry matrices remained to be established. 260 
Cultivar Durone Nero I was also characterized by a high content of anthocyanins. In this cherry 261 
cultivar, anthocyanins represented the phenolic class with highest bioaccessibility (55.0%), 262 
constituting the 28.2% of total phenolic compounds after in vitro digestion (Figure 1G and 1H and 263 
Table 1). Anthocyanins are generally considered very unstable compounds under slightly alkaline 264 
conditions as found in the intestinal milieu. For example, in vitro digestion of red wine, chokeberry, 265 
and pomegranate juice resulted in a substantial degradation of monomeric anthocyanins (Bermúdez-266 
Soto et al. 2007; Lingua et al. 2018; Perez-Vicente et al. 2002). Anthocyanins stability in the 267 
digestive system appeared to be related to their molecular structure. The presence of a methoxy 268 
group in the B-ring stabilized the anthocyanin structure (Yang et al. 2018). The acetylated 269 
derivatives of anthocyanins showed relatively higher stability during the gastro-intestinal transit 270 
than simple anthocyanins (Yang et al. 2018). As shown in Table 1, the rutinoside derivatives of 271 
cherry anthocyanins were more stable than the corresponding glycosidic forms. These results are in 272 
agreement with Fazzari et al. (2008). It can be speculated that fruits containing high levels of 273 
rutinoside derivatives are likely to provide larger amounts of anthocyanins in the colon. Indeed, 274 
peonidin-3-O-rutinoside, which is characterized by the presence of a rutinose moiety and a methoxy 275 
group in the B-ring showed 100% of bioaccessibility. 276 
Some newly identified compounds were indicative of anthocyanins degradation (Table 1). 277 
Protocatechuic acid appeared after in vitro digestion of cherry cultivars and plausibly came from the 278 
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degradation of cyanidin-3-O-glucoside. Moreover, cyanidin-3-O-glucoside chalcone was also found 279 
after in vitro digestion of Durone Nero I due to the presence of its [M+H]+ precursor ion at 467 and 280 
product ions at m/z 305 (-162 amu; loss of a glucosyl moiety), m/z 449 (-18 amu; loss of water) and 281 
m/z 287 (-18-162 amu; loss of water and glucosyl moiety) (Lopes et al. 2007). After in vitro 282 
digestion of Durone Nero I, a new compound with a [M+H]+ mass signal at 737 was detected. In 283 
ESI positive experiments, it gave a base peak product ion at m/z 575 (-162 amu) corresponding to 284 
the loss of a glucosyl moiety. Additional product ions were detected at m/z 557 (loss of water from 285 
m/z 575) and m/z 287 (loss of a (epi)catechin unit from m/z 575). Finally, a product ion at m/z 423 286 
was detected corresponding to the loss of 152 amu from m/z 575 resulting from the retro Diels-287 
Alder decomposition of the flavan-3-ol unit. The described fragmentation pattern corresponded to 288 
that previously observed for a (epi)catechin-cyanidin-3-O-glucoside dimer (Sentandreu et al. 2010). 289 
The bioaccessibility of the other phenolic classes was very low with the exception of flavonols 290 
(52.2% and 39.3% of bioaccessibility in the cultivars Celeste and Durone Nero I, respectively) 291 
(Figure 1D and Table 1). However, due to their low concentration in the cherries, they represented 292 
only the 1.5% and 4.4% of total phenolic compounds determined after in vitro digestion in the 293 
cultivars Celeste and Durone Nero I, respectively (Figure 1H and Table 1). 294 
 295 
3.2 Effect of in vitro digestion on the antioxidant properties 296 
To fully characterize the antioxidant properties of the phenolic-rich fractions of cherries, the 297 
ability to scavenge some physiologically relevant radicals (superoxide anion and hydroxyl radical) 298 
and the organic nitro-radical ABTS as well as the reducing power were evaluated before and after 299 
digestion (Figure 3). 300 
The hydroxyl radical scavenging capacity of phenolic-rich extracts decreased after in vitro digestion 301 
of both the cherry cultivars (Figure 3A). This means that cherry phenolic compounds in the 302 
chemical extracts were more efficient scavengers of hydroxyl radical than the phenolic compounds 303 
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present in the digested cherries. This decrease may reflect the different composition of the chemical 304 
and in vitro digested phenolic-rich extracts. In both the cherry cultivars, the in vitro digested 305 
extracts were enriched in hydroxycinnamic acids (Table 1 and Figure 1H) that showed the lowest 306 
hydroxyl scavenging activity among phenolic compounds (Özyürek et al. 2008). On the contrary, 307 
ferric reducing power of the phenolic-rich extracts increased after in vitro digestion (Figure 3B). 308 
This clearly reflected the different composition of the chemical and digested extracts, since the 309 
ferric reducing ability of hydroxycinnamic acids is considered higher than that of flavan-3-ols 310 
(Pulido et al. 2000). The superoxide anion scavenging activity instead was similar between the 311 
phenolic-rich extracts before and after in vitro digestion (Figure 3C). Finally, the ABTS radical 312 
scavenging activity assay displayed a different behaviour in the two cherry cultivars (Figure 3D). 313 
In Celeste cultivar, the phenolic-rich extract obtained after in vitro digestion showed a lower 314 
scavenging ability than the extract before digestion. This is in keeping with the observed percent 315 
increase in hydroxycinnamic acids that showed lower ABTS radical scavenging activity respect to 316 
flavan-3-ols (Rice-Evans et al. 1996). Instead, in the cultivar Durone Nero I we observed an 317 
increase in the ABTS radical scavenging activity in the phenolic-rich extract after in vitro digestion. 318 
This can be related to the percentage increase of anthocyanins and flavonols in the digested extracts 319 
(Table 1 and Figure 1H), which displayed greater ABTS radical scavenging activity than flavan-3-320 
ols (Rice-Evans et al. 1996). 321 
Indeed, it is important to note that the different incidence of the phenolic classes in the digested 322 
phenolic-rich extracts gave rise to significant different behaviours in the scavenging capacity or 323 
reducing power in relation to the type of assay and mechanism involved, leading to an increase or 324 
decrease of the considered activities. 325 
 326 
3.3 Anti-proliferative activity of cherry phenolic-rich fractions on human colon adenocarcinoma 327 
cell lines  328 
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The effect of cherry phenolic-rich fractions extracted before and after in vitro gastro-intestinal 329 
digestion on the proliferation of human colon adenocarcinoma Caco-2 and SW480 cells was 330 
investigated. Caco-2 and SW480 cells were incubated with different concentrations of phenolic-rich 331 
extracts for 24 h. Cherry phenolic-rich extracts did not affect the proliferation of Caco-2 (data not 332 
shown). Instead, the phenolic compounds from the chemical extracts of both the cultivars were able 333 
to inhibit in a dose-dependent manner the proliferation of SW480 cell line (Figure 4). The chemical 334 
extract of cultivar Durone Nero I was about 2.5 times more efficient than Celeste with IC50 values 335 
of 48.01 ± 3.02 and 121.90 ± 5.03 μmol/L, respectively. In vitro digestion positively affected the 336 
anti-proliferative activity of Celeste phenolic-rich fraction. As reported in Figure 4, the IC50 value 337 
of phenolic compounds extracted after digestion of cultivar Celeste halved to 61.22 ± 4.02 μmol/L. 338 
No significant differences were found between the IC50 values calculated for cultivar Durone Nero I 339 
before and after digestion. 340 
According to the literature, this is the first report investigating the anti-proliferative activity of 341 
sweet cherry phenolic-rich extracts against human colon adenocarcinoma Caco-2 and SW480 cell 342 
lines and the influence of in vitro digestion processes. 343 
Previous in vitro studies have shown anti-proliferative properties of sweet cherry extracts against 344 
colon cancer cell lines such as HCT-15 and HT29 (Bastos et al. 2015; Serra et al. 2011). This effect 345 
has been attributed to the anthocyanin content of the cherry extracts (Wang and Stoner 2008). 346 
However, Olsson et al. (2008) found no correlation between proliferation of HT29 cells and 347 
the concentration of anthocyanins in ten fruits and berries (including cherries). In accordance, also 348 
in this study we did not find any correlation between the anthocyanin content and the anti-349 
proliferative activity. In fact, Durone Nero I chemical extract contained five times more 350 
anthocyanins than Celeste chemical extract but exhibited only 2.5 times more anti-proliferative 351 
activity. Indeed, in vitro digested phenolic fraction from Celeste was as effective as Durone Nero I 352 
chemical extract although it did not contain anthocyanins.  353 
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Our results suggested that other compounds rather than anthocyanins can be responsible for the 354 
observed anti-proliferative effect of phenolic-rich fractions extracted before and at the end of the in 355 
vitro gastro-intestinal digestion.  356 
 357 
3.4. Metabolism of cherry phenolic compounds in cell cultures 358 
In an attempt to unravel the metabolism of cherry phenolic compounds by Caco-2 and SW480, cell 359 
media were collected after 24 h of incubation with in vitro digested Durone Nero I phenolic-rich 360 
fraction and subjected to LC-MS ion trap analysis. Some parent compounds and newly formed 361 
metabolites were detected in both cell types and reported in Table 2.  362 
Total coumaroylquinic acids final concentration accounted for the 13.9 and 14.7% of the initial 363 
concentration in the cultured Caco-2 and SW480, respectively. In addition to the coumaroylquinic 364 
acid isomers, one newly formed metabolite was tentatively identified as coumaroylquinic acid 365 
sulphate in the cell media of both the cell lines. The rate of sulphation of coumaroylquinic acid 366 
isomers in SW480 was 0.5%, while in Caco-2 coumaroylquinic acid sulphate was found only at 367 
trace levels. To the best of our knowledge, this is the first report showing sulphation of 368 
coumaroylquinic acids by Caco-2 and SW480. Coumaric and (iso)ferulic acids were found in the 369 
media after incubation with both cell lines, whereas caffeic acid only after incubation with SW480 370 
(Table 2). The appearance of these simple hydroxycinnamic acids, which were not present in the 371 
digested sample, was accompanied by the disappearance of caffeoylquinic and feruloylquinic acids 372 
(with the exception of trace amounts of 3-feruloylquinic acid) and the decrease in concentration of 373 
coumaroylquinic acids. These results can be indicative of hydroxycinnamoyl-quinic acids 374 
degradation in the media or to the hydrolysis catalysed by esterases. Considering the initial 375 
concentration of feruloylquinic acids, their complete hydrolysis during incubation with cells should 376 
result in a (iso)ferulic acid concentration of 10.47 μmol/L. However, the amount of (iso)ferulic acid 377 
found in cell medium after 24 h of incubation with Caco-2 was about 5.5 times higher (Table 2). 378 
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Previous studies have shown that Caco-2 possess catechol-O-methyltransferase able to metabolize 379 
caffeic acid to (iso)ferulic acid (Monente et al. 2015; Farrell et al. 2011; Kern et al. 2003). 380 
Therefore, the exceeded amount of (iso)ferulic acid can be a consequence of the methylation of 381 
caffeic acid released from hydrolysis of caffeoylquinic acids. The mass balance recovery of 382 
(iso)ferulic acid also considering the initial amount of caffeoylquinic acids present in the digested 383 
sample was 35.6%, suggesting the partial methylation of caffeic acid released after hydrolysis of 384 
caffeoylquinic acids. This conclusion is also supported by the lack of identification of caffeic acid 385 
in the medium after 24 h of incubation with Caco-2. 386 
The same conclusions can not be drawn for SW480. In the medium of this cell line, we found some 387 
residual caffeic acid and the amount of (iso)ferulic acid was 1.2 times higher respect than the 388 
amount found at the end of the digestion (Table 2). It can be speculated that SW480 expressed 389 
lower amount of catechol-O-methyltransferase or that the isoform in these cells had a lower affinity 390 
for caffeic acid respect to the isoform in Caco-2 cells. 391 
Another difference between the two cell lines was related to the ability to metabolize glycosylated 392 
flavonols. Caco-2 cells were found to be able to hydrolyse quercetin-3-O-glucoside to the 393 
corresponding aglycone. Furthermore, a newly formed metabolite, quercetin-3-O-glucoside 394 
sulphate appeared in the cell medium after 24 h of incubation with Caco-2. The ability of Caco-2 395 
cells to hydrolyse glycosylated flavonols was previously reported (Boyer et al. 2004). Finally, 396 
glycosylated flavonols tended to be accumulated after 24 h of incubation with SW480 cell line. 397 
 398 
4. Conclusions 399 
Bioactivity of phenolic compounds is primarily conditioned by their bioaccessibility in the gastro-400 
intestinal tract, and secondly on their cellular uptake and internal transformation. The present study 401 
determined the amounts of bioaccessible phenolic compounds from two cherry cultivars after in 402 
vitro gastro-intestinal digestion. Results showed that the digestion process modified from a 403 
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qualitative and quantitative point of view the profile of phenolic compounds in the samples. 404 
Hydroxycinnamic acids and flavonols showed the highest bioaccessibility. Isomerisation of 405 
caffeoylquinic and coumaroylquinic acids was observed after in vitro gastro-intestinal digestion. 406 
We have also demonstrated that Caco-2 and SW480 cell lines showed metabolic activity resulting 407 
in a partial modification of cherry phenolic compounds. Methylation, sulphation, de-glycosylation 408 
and hydrolysis of esters were the main pathways of phenolic compounds metabolism in the tested 409 
cell lines. Moreover, we demonstrated that bioaccessible cherry phenolic compounds showed anti-410 
proliferative activity against two models of human colon adenocarcinoma cell lines. The presence 411 
of (iso)ferulic acid in Caco-2 cell medium at higher concentration than in SW480 cell medium or 412 
the presence of caffeic acid only in SW480 cell medium and quercetin and quercetin-3-O-glucoside 413 
sulphate only in Caco-2 cell medium may suggest the intrinsic differences among the two cell lines 414 
and the metabolic mechanisms involved. The different effects on the two tested cell lines can be 415 
related to the accumulation of glycosylated flavonols in the cell medium of SW480 or to a different 416 
sensitivity of the cell lines to the phenolic compounds. Nevertheless, it could be interesting to 417 
underline how the sensitivity to the presence of phenolic-rich extracts increased after digestion, 418 
where the hydroxycinnamic acids were the major phenolic class present. 419 
Further studies are necessary in order to confirm the proposed pathways of metabolism of cherry 420 
phenolic compounds during incubation with cell lines and the potential role of hydroxycinnamic 421 
acids.422 
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Figure captions 
Figure 1. Bioaccessibility of individual phenolic compounds identified and quantified by LC-
ESI-IT MS/MS grouped by classes. (A) Sum of the different classes; (B) hydroxycinnamic acids; 
(C) flavan-3-ols; (D) flavonols; (E) other flavonoids; (F) hydroxybenzoic acids; (G) anthocyanins. 
Dark grey columns represent the amount of the individual classes found in the chemical extract 
whereas light grey columns the amount at the end of the digestion. (H) Percent incidence of the 
different classes.  UC: un-digested Celeste; DC: digested Celeste; UDN: un-digested Durone Nero 
I; DDN: digested Durone Nero I. (     ) Anthocyanins; (     ) other flavonoids; (     ) flavan-3-ols; 
(     ) flavonols; (     ) hydroxycinnamic acids; (     ) hydroxycinnamic acids. Results are expressed as 
mean ± standard deviation. Values in the same graph with different lowercase letters are 
significantly different (P < 0.05). 
Figure 2. Bioaccessibility of individual hydroxycinnamic acids isomers. (A, C and E) Celeste 
cultivar; (B, D and F) Durone Nero I cultivar. Black columns represent the amount of the individual 
isomers found in the chemical extracts whereas grey columns the amount at the end of the 
digestion. CQA: caffeoylquinic acids; FQA: feruloylquinic acids; CoQA: coumaroylquinic acids. 
Results are expressed as mean ± standard deviation. Values in the same graph with different 
lowercase letters are significantly different (P < 0.05). 
Figure 3. Antioxidant properties of un-digested and in vitro digested cherry phenolic-rich 
fractions. Antioxidant capacity measured as hydroxyl radical scavenging capacity (A), ferric 
reducing power (FRAP) (B), superoxide anion scavenging capacity (C) and ABTS radical 
scavenging activity (D). Black columns show data from the chemical extracts whereas grey 
columns from the extracts at the end of the digestion. Results are expressed as mean ± standard 
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deviation. Values in the same graph with different lowercase letters are significantly different (P < 
0.05). 
Figure 4. Anti-proliferative activity of un-digested and in vitro digested cherry phenolic-rich 
fractions. IC50 is defined as the concentration of phenolic compounds required to inhibit 50% of 
cell proliferation. The amount of phenolic compounds was determined by LC-ESI-IT MS/MS 
analysis. Dark grey columns represent the activity of the chemical extracts whereas light grey 
columns the activity of the extracts at the end of the digestion. Results are expressed as mean ± 
standard deviation. Values in the same graph with different lowercase letters are significantly 
different (P < 0.05). 
Table 1. Quantitative results (μmol/100 g fresh weight fruit) for phenolic compounds identified in 
the cherry phenolic-rich fractions obtained from both chemical extraction and after gastro-intestinal 
digestion. Values represent means ± standard deviation of triplicate determination.* 
 
Compound Celeste Durone Nero I 
 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
     Hydroxycinnamic acids 
3-Caffeoylquinic acid cis 31.90 ± 1.76b 8.44 ± 0.45c 37.87 ± 0.28a 3.54 ± 0.51d 
3-Caffeoylquinic acid trans 123.91 ± 5.43b 33.06 ± 0.72c 197.17 ± 0.75a 33.36 ± 0.40c 
4-Caffeoylquinic acid cis 1.44 ± 0.03c 6.23 ± 0.45a 2.51 ± 0.22b 2.19 ± 0.01b 
5-Caffeoylquinic acid trans 85.03 ± 3.50b 17.23 ± 0.31c 170.27 ± 6.56a 14.64 ± 0.17c 
4-Caffeoylquinic acid trans 2.75 ± 0.07b 37.85 ± 0.42a n.d. 36.57 ± 0.17a 
5-Caffeoylquinic acid cis 11.91 ± 0.08b 3.70 ± 0.06c 26.37 ± 0.11a 2.05 ± 0.01d 
3-Coumaroylquinic acid cis 464.38 ± 11.74a 89.38 ± 4.12c 383.90 ± 20.47b 54.94 ± 2.66d 
3-Coumaroylquinic acid trans 551.01 ± 5.45b 212.71 ± 3.28d 1278.30 ± 14.14a 351.02 ± 5.85c 
4-Coumaroylquinic acid cis 2.09 ± 0.04d 136.06 ± 3.46a 38.18 ± 0.96c 102.24 ± 1.10b 
4-Coumaroylquinic acid trans 29.45 ± 1.43d 287.86 ± 2.17b 50.91 ± 0.76c 319.44 ± 2.67a 
5-Coumaroylquinic acid trans 1.54 ± 0.06c 78.95 ± 1.25a 4.32 ± 0.16b 81.85 ± 2.69a 
5-Coumaroylquinic acid cis 2.07 ± 0.11c 49.25 ± 0.72a 2.72 ± 0.11c 32.77 ± 0.36b 
3-Feruloylquinic acid cis 5.30 ± 0.07a 3.05 ± 0.03b 4.94 ± 0.09a 1.84 ± 0.05c 
3-Feruloylquinic acid trans 6.98 ± 0.19a 2.59 ± 0.07b  2.03 ± 0.01c 2.13 ± 0.02c 
4-Feruloylquinic acid cis 0.97 ± 0.07c 2.79 ± 0.05a 1.10 ± 0.03c 1.96 ± 0.03b 
5-Feruloylquinic acid trans 0.39 ± 0.02c 1.02 ± 0.06a 0.69 ± 0.03b n.d. 
5-Feruloylquinic acid cis 5.59 ± 0.05b 0.69 ± 0.01c 8.24 ± 0.24a 0.35 ± 0.01c 
Caffeoylquinic acid-hexoside isomer 1.21 ± 0.03a n.d. 1.20 ± 0.03a n.d. 
Caffeoylquinic acid-hexoside isomer 1.05 ± 0.02b 1.04 ± 0.08b 2.07 ± 0.07a 0.78 ± 0.02c 
3,5-diCaffeoylquinic acid 3.38 ± 0.03b n.d. 5.60 ± 0.12a n.d. 
4,5-diCaffeoylquinic acid 1.64 ± 0.02b n.d. 2.06 ± 0.17a n.d. 
Caffeoylshikimic acid isomer 1.58 ± 0.04a n.d. 0.75 ± 0.09b n.d. 
3- and 4-Caffeoylquinic lactone 1.99 ± 0.01a n.d. 2.26 ± 0.15a n.d. 
Caffeoylshikimic acid isomer 0.67 ± 0.03 n.d. n.d. n.d. 
3-Coumaroylquinic lactone 1.09 ± 0.03 n.d. n.d. n.d. 
4-Coumaroylquinic  lactone 1.90 ± 0.04b n.d. 5.46 ± 0.10a n.d. 
3-Coumaroyl-5-caffeoylquinic acid 0.94 ± 0.05b n.d. 1.78 ± 0.08a n.d. 
3-Caffeoyl-4-coumaroylquinic acid 0.90 ± 0.07 n.d. n.d. n.d. 
Caffeoyl-hexose isomer 0.57 ± 0.02b n.d. 2.21 ± 0.21a n.d. 
Caffeic acid-hexoside isomer 2.94 ± 0.13b n.d. 8.70 ± 0.26a n.d. 
Caffeoyl alcohol 3/4-O-hexoside  2.21 ± 0.11 n.d. n.d. n.d. 
Feruloyl-hexose isomer 6.17 ± 0.05 n.d. n.d. n.d. 
Sinapoyl-hexose isomer n.d. n.d. 0.94 ± 0.02a 0.82 ± 0.02b 
Sinapic acid-hexoside 0.93 ± 0.02 n.d. n.d. n.d. 
Total hydroxycinnamic acids 1354.99 ± 4.49b 971.91 ± 3.22d 2242.57 ± 5.69a 1042.51 ± 2.87c 
Flavan-3-ols 
Catechin 127.92 ± 3.20b n.d. 229.51 ± 6.86a 1.86 ± 0.08c 
Epicatechin 772.30 ± 4.82b n.d. 1369.61 ± 12.58a 11.16 ± 0.17c 
(Epi)catechin-3-gallate 10.75 ± 0.23a 4.30 ± 0.22c 8.41 ± 0.09b 4.86 ± 0.03c 
(Epi)catechin-hexoside isomer 16.03 ± 0.59b n.d. 26.78 ± 0.42a 1.35 ± 0.05c 
Procyanidin tetramer B type isomer 3.40 ± 0.19b n.d. 10.17 ± 0.14a n.d. 
Procyanidin dimer B type isomer 13.17 ± 1.80b n.d. 21.66 ± 2.58a 0.77 ± 0.01c 
Procyanidin dimer B type isomer 65.66 ± 1.08b n.d. 91.27 ± 1.98a 1.05 ± 0.04c 
Procyanidin dimer B type isomer 7.11 ± 0.46b n.d. 12.22 ± 0.15a 0.94 ± 0.02c 
Propelargonidin dimer isomer n.d. n.d. 2.65 ± 0.06 n.d. 
Procyanidin pentamer B type isomer 2.59 ± 0.21b n.d. 5.79 ± 0.23a n.d. 
Total flavan-3-ols 1018.94 ± 6.21b 4.30 ± 0.22d 1778.07 ± 14.71a 21.99 ± 0.20c 
Flavonols 
Quercetin-3-O-rutinoside 15.69 ± 0.42c 6.09 ± 0.07d 102.25 ± 2.09a 29.72 ± 0.14b 
Quercetin-3-O-glucoside 1.40 ± 0.03c 0.64 ± 0.02d 40.90 ± 0.22a 26.41 ± 0.15b 
Quercetin-7-O-hexoside-3-O-
rutinoside 7.53 ± 0.06
b
 6.07 ± 0.14b 11.90 ± 0.13a 3.53 ± 0.07c 
Kaempferol-3-O-hexoside n.d. n.d. 2.93 ± 0.07a 2.39 ± 0.05a 
Kaempferol-3-O-rutinoside 2.97 ± 0.06c 1.31 ± 0.02d 17.53 ± 0.14a 7.04 ± 0.06b 
Kaempferol-7-O-hexoside-3-O-
rutinoside 1.44 ± 0.07
b
 1.05 ± 0.01c 2.33 ± 0.02a 0.76 ± 0.01c 
Total flavonols 29.02 ± 0.44c 15.16 ± 0.16d 177.83 ± 2.11a 69.85 ± 0.23b 
Other flavonoids 
Naringenin-hexoside 0.81 ± 0.01b n.d. 4.18 ± 0.24a n.d. 
Taxifolin-rutinoside isomer 10.01 ± 0.26b n.d. 151.92 ± 11.33a 2.09 ± 0.08c 
Taxifolin-rutinoside isomer 6.70 ± 0.12b n.d. 38.12 ± 0.19a 2.02 ± 0.05c 
Taxifolin-hexoside isomer n.d. n.d. 78.53 ± 1.02a 2.27 ± 0.03b 
Taxifolin-hexoside isomer n.d. n.d. 24.13 ± 0.09a 2.10 ± 0.04b 
Total other flavonoids 17.53 ± 0.29b n.d. 296.88 ± 11.38a 8.49 ± 0.10c 
Hydroxybenzoic acids 
Protocatechuic acid n.d. 0.13 ± 0.01b n.d. 0.34 ± 0.01a 
Protocatechuoyl-hexose 0.52 ± 0.01b n.d. 1.05 ± 0.08a n.d. 
Hydroxybenzoic acid-hexoside 0.41 ± 0.01 n.d. n.d. n.d. 
Vanillic acid-hexoside 2.96 ± 0.10b n.d. 5.24 ± 0.24a n.d. 
Total hydroxybenzoic acids 3.89 ± 0.10b 0.13 ± 0.01d 6.29 ± 0.25a 0.34 ± 0.01c 
Anthocyanins and derivatives 
Cyanidin-3-O-glucoside  2.49 ± 0.03c n.d. 317.02 ± 12.32a 86.91 ± 0.56b 
Cyanidin-3-O-rutinoside  68.77 ± 0.74c 0.59 ± 0.02d 480.05 ± 4.82a 346.74 ± 2.14b 
Cyanidin-5-O-hexoside-3-O-
coumaroyl-hexoside n.d. n.d. 0.97 ± 0.01 < LOQ 
Cyanidin-3-O-glucoside chalcone n.d. n.d. n.d. 0.07 ± 0.01 
(Epi)catechin-cyanidin-3-O-
glucoside dimer n.d. n.d. n.d. 0.09 ± 0.01 
Peonidin-3-O-rutinoside 5.07 ± 0.09b n.d. 13.43 ± 0.14a 13.94 ± 0.17a 
Pelargonidin-3-O-rutinoside  0.27 ± 0.01c n.d. 3.85 ± 0.50a 1.47 ± 0.04b 
Pelargonidin-3-O-hexoside n.d. n.d. 1.59 ± 0.20a 0.32 ± 0.01b 
Total anthocyanins 76.60 ± 0.74c 0.59 ± 0.02d 816.92 ± 13.24a 449.53 ± 2.22b 
Total phenolic compounds 2500.96 ± 3.99b 992.10 ± 3.23d 5318.56 ± 23.61a 1592.71 ± 3.67c 
*Hydroxycinnamic acids were quantified as 5-caffeoylquinic acid equivalent; flavan-3-ols were quantified as 
epicatechin equivalent; flavonols and other flavonoids were quantified as quercetin-3-glucoside equivalent; 
hydroxybenzoic acids were quantified as gallic acid equivalent; anthocyanins and derivatives were quantified as 
cyanidin-3-glucoside equivalent.  
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
<LOQ means the compound was detected but it was below the limit of quantification.  
n.d. means not detected 
 
 
Table 2. Phenolic compounds extracted from in vitro digested Durone Nero I identified in the cell 
media after 24 h of incubation with Caco-2 and SW480. Results are expressed as μmol/L*. In 
bracket the percentage of recovery respect to the time zero (before incubation with cells). 
 *Hydroxycinnamic acids were quantified as 5-caffeoylquinic acid equivalent, whereas flavonols were quantified as 
quercetin-3-glucoside equivalent. 
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
<LOQ means the compound was detected but it was below the limit of quantification.  
n.d. means not detected 
 
 
 
 
Compounds [M-H]- Fragment ions 
Caco-2 
μmol/L 
SW480 
μmol/L 
     
3-Coumaroylquinic acid cis 337 163, 119, 191 19.56 ± 0.20 (21.4)
b
 55.49 ± 0.16 (60.6)a 
3-Coumaroylquinic acid trans 337 163, 119, 191 47.18 ± 2.79 (8.1)
a 44.35 ± 0.06 (7.6)a 
4-Coumaroylquinic acid cis 337 173, 163 22.69 ± 0.47 (4.3)b 48.80 ± 2.29 (9.2)a 
4-Coumaroylquinic acid trans 337 173, 163 59.96 ± 4.77 (32.8)a 37.31 ± 0.32 (21.9)b 
5-Coumaroylquinic acid trans 337 191, 173, 163 45.44 ± 1.26 (33.3)
a 21.49 ± 0.55 (15.8)b 
5-Coumaroylquinic acid cis 337 191, 163, 173 27.50 ± 0.51 (50.4)
a 23.71 ± 1.22 (43.4)a 
Total coumaroylquinic acids / / 218.33 ± 5.71 (13.9)b 231.14 ± 7.30 (14.7)a 
Coumaroylquinic acid 
sulphate 417 337, 163 < LOQ 7.83 ± 0.54 
Caffeoylquinic acid-hexoside 
isomer 515 
341, 353, 
179 < LOQ n.d. 
3-Feruloylquinic acid 367 193 < LOQ n.d. 
Caffeic acid 179 135 n.d. < LOQ 
(Iso)ferulic acid 193 178 58.47 ± 4.40a 12.62 ± 0.52b 
Coumaric acid 163 119 4.11 ± 5.71 < LOQ 
Dihydro-caffeic acid 181 137 n.d. < LOQ 
Quercetin-3-O-rutinoside 609 301 n.d. 26.84 ± 0.15 (54.2) 
Quercetin-3-O-glucoside 463 301 n.d. 9.80 ± 0.19 (22.3) 
Quercetin-3-O-glucoside 
sulphate 543 381, 301 < LOQ n.d. 
Quercetin 301 179, 151 < LOQ n.d.. 
Kaempferol-3-O-rutinoside 593 285, 255 5.99 ± 0.08 (51.0)b 9.17 ± 0.49 (78.1)a 




